期刊文献+

腹膜透析相关性腹膜炎致病菌及耐药性分析 被引量:22

Pathogens causing peritoneal dialysis-related peritonitis and their drug resistance
原文传递
导出
摘要 目的探讨持续性非卧床腹膜透析(CAPD)相关性腹膜炎的致病菌及其耐药性。方法回顾性分析49例CAPD腹膜炎患者的病原菌、耐药性和转归。结果 31例培养阳性,透出液培养阳性率为63.27%;共培养菌株34株,其中革兰阳性菌22株,革兰阴性菌9株,真菌3株,最常见的病原菌为表皮葡萄球菌和大肠埃希菌;革兰阳性菌对阿米卡星、利奈唑胺、万古霉素、替考拉宁耐药率最低,分别为0、0、4.76%、5.56%,其次为头孢唑林、左氧氟沙星、哌拉西林/他唑巴坦,分别为35.00%、36.36%、37.50%;革兰阴性菌对阿米卡星、亚胺培南耐药率最低,均为0,其次为哌拉西林/他唑巴坦、头孢哌酮/舒巴坦,均为37.50%,对头孢他啶的耐药率为77.78%。结论腹膜透析相关性腹膜炎致病菌仍以革兰阳性菌为主;腹膜炎患者经验治疗可选用哌拉西林/他唑巴坦单一用药;头孢唑林联合头孢哌酮/舒巴坦;左氧氟沙星联合头孢哌酮/舒巴坦;无残存肾功能者可单独选用阿米卡星。 OBJECTIVE To investigate the pathogens and their resistance in CAPD-related peritonitis.METHODS Pathogens,resistance and outcomes of 49 cases of CAPD-related peritonitis were analyzed retrospectively.RESULTS Totally 31 cases were cultured positive with a positive rate of 63.27%.A total of 34 strains were cultured,including 22 Gram-positive strains,9 Gram-negative strains and 3 fungi strains.The most common pathogens were Staphylococcus epidermidis and Escherichia coli.Gram-positive bacteria showed lowest resistance rate to amikacin(0),linezolid(0),vancomycin(4.76%) and teicoplanin(5.56%),followed by cefazolin(35.00%),levofloxacin(36.36%),piperacillin/tazobactam(37.5%).Gram-negative bacteria showed lowest resistance to amikacin(0),imipenem(0),then were piperacillin/tazobactam(37.5%),cefoperazone/sulbactam(37.50%),the resistance rate to ceftazidime was 77.78%.CONCLUSION Gram-positive bacteria are the predominant pathogens causing peritoneal dialysis-related peritonitis.Experience in treating patients with peritonitis can choose:piperacillin/tazobactam monotherapy;cefazolin joint cefoperazone/sulbactam;levofloxacin joint cefoperazone/sulbactam;those without residual renal function may use amikacin alone.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第16期3521-3523,共3页 Chinese Journal of Nosocomiology
关键词 腹膜透析 腹膜炎 耐药性 Peritoneal dialysis Peritonitis Drug resistance
  • 相关文献

参考文献5

  • 1Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations:2010 update[J]. Petit Dial Int, 2010,30(4) : 393-423.
  • 2Yoon SH,Choi NW,Yun SR. Detecting bacterial growth in con- tiruous ambulatory peritoneal dialysis effluent using two culture methods[J]. Korean J Intern Med,2010,25(1) :82-85.
  • 3Shigidi MM, Fituri OM, Chandy SK, et al. Microbial spec- trum and outcome of peritoneal dialysis related peritonitis in Qatar[J]. Saudi J Kidney Dis Transpl, 2010,21 (1) : 168-173.
  • 4Strippoli GF,Tong A,Johnson D,et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004,18 (4) :CD004679.
  • 5Lui SL, Cheng SW, Ng SY, et al. Cefazolin plus netilmicin versus cefazolin plus eeftazidime for treating CAPD peritonitis: effect on residual renal function[J]. Kidney Int,2005,68(5) :2375-2380.

同被引文献177

引证文献22

二级引证文献127

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部